eople with type 2 diabetes who take a proton pump inhibitor (PPI) drug are at greater risk for cardiovascular disease and death, according to a new study published in the Journal
PPIs LINKED TO CARDIO EVENTS IN T2D
May 20, 2023
1 minute
You’re reading a preview, subscribe to read more.
Start your free 30 days